Tirzepatide 40 mg (Lyophilized Powder) – Dual-Action Support for Weight Loss & Glycemic Control
Tirzepatide 40 mg is a lyophilized (freeze-dried) peptide formulation, designed for reconstitution and use under medical supervision. As a dual GIP and GLP-1 receptor agonist, Tirzepatide offers a powerful approach to weight management and blood sugar regulation—addressing key metabolic pathways with enhanced clinical efficacy.
 
This high-strength 40 mg vial is ideal for advanced protocols requiring customised dosing, particularly for individuals seeking more aggressive intervention in obesity or type 2 diabetes care.
 
Key Features:
40 mg Tirzepatide per vial (lyophilized powder)
Requires reconstitution prior to administration
Dual agonist of GIP and GLP-1 receptors for enhanced metabolic impact
Clinically shown to significantly reduce body weight and improve HbA1c levels
Ideal for clinical compounding, professional use, or supervised at-home programs
 
Usage Information:
This product is intended for reconstitution with bacteriostatic water or as directed by a qualified healthcare provider. For sterile use only. Proper handling and dosing under medical guidance are essential for safe and effective outcomes.
 
FOR RESEARCH PURPOSES ONLY.